Roy Andrew Morgan
Director/Miembro de la Junta en Stemina Biomarker Discovery, Inc. .
Perfil
Roy Andrew Morgan is currently the Director at Stemina Biomarker Discovery, Inc., as well as the EVP-Regulatory Affairs & Quality Operations at both Zurex Pharma, Inc. and Zurex PharmAgra LLC.
Previously, he held positions as Director-Regulatory Affairs at Celltech Pharmaceuticals, Inc., VP-Regulatory, Quality & Pharmaceutical Sciences at Bone Care International, Inc., Vice President-Quality Operations at Genzyme Corp., and Manager-Regulatory Affairs & Labeling at Medeva Pharmaceuticals, Inc. Morgan received his undergraduate degree from Southwestern Oklahoma State University.
Cargos activos de Roy Andrew Morgan
| Empresas | Cargo | Inicio |
|---|---|---|
Stemina Biomarker Discovery, Inc.
 Stemina Biomarker Discovery, Inc. BiotechnologyHealth Technology Stemina Biomarker Discovery, Inc. engages in the development and commercialization of molecular biomarkers to improve drug safety and human health. Its products and services include Cardio quickPredict, devTOX quickPredict, and TOXquickPredict. The company was founded by Elizabeth L. R. Donley and Gabriela G. Cezar in November 2006 and is headquartered in Madison, WI. | Director/Miembro de la Junta | - |
Zurex Pharma, Inc.
 Zurex Pharma, Inc. Medical SpecialtiesHealth Technology Zurex Pharma, Inc. provides safe and effective anti-microbial products. Its products include ZuraPrep, a pre-surgical skin preparation for the prevention of SSI; ZurAsept, an antimicrobial and antithrombotic catheter solution to reduce CRBSI; and ZuraGard that prevents extra-luminal or exit site wound CRBSI. The company was founded in April 2008 and is headquartered in Middleton, WI. | Consejero General | - |
| Zurex PharmAgra LLC | Consejero General | - |
Antiguos cargos conocidos de Roy Andrew Morgan.
| Empresas | Cargo | Fin |
|---|---|---|
Bone Care International, Inc.
 Bone Care International, Inc. Pharmaceuticals: OtherHealth Technology Bone Care International, Inc. developed innovative therapeutic products. Its products included Hectorol Injections and Capsules. The company was located in Middleton, WI. | Consejero General | - |
Medeva Pharmaceuticals, Inc.
 Medeva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of UCB SA, Medeva Pharmaceuticals, Inc. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Rochester, NY. Medeva Pharmaceuticals was founded in 1998. | Consejero General | - |
| Celltech Pharmaceuticals, Inc. | Consejero General | - |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formación de Roy Andrew Morgan.
| Southwestern Oklahoma State University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 7 |
|---|---|
Bone Care International, Inc.
Bone Care International, Inc. Pharmaceuticals: OtherHealth Technology Bone Care International, Inc. developed innovative therapeutic products. Its products included Hectorol Injections and Capsules. The company was located in Middleton, WI. | Health Technology |
Stemina Biomarker Discovery, Inc.
Stemina Biomarker Discovery, Inc. BiotechnologyHealth Technology Stemina Biomarker Discovery, Inc. engages in the development and commercialization of molecular biomarkers to improve drug safety and human health. Its products and services include Cardio quickPredict, devTOX quickPredict, and TOXquickPredict. The company was founded by Elizabeth L. R. Donley and Gabriela G. Cezar in November 2006 and is headquartered in Madison, WI. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Zurex Pharma, Inc.
Zurex Pharma, Inc. Medical SpecialtiesHealth Technology Zurex Pharma, Inc. provides safe and effective anti-microbial products. Its products include ZuraPrep, a pre-surgical skin preparation for the prevention of SSI; ZurAsept, an antimicrobial and antithrombotic catheter solution to reduce CRBSI; and ZuraGard that prevents extra-luminal or exit site wound CRBSI. The company was founded in April 2008 and is headquartered in Middleton, WI. | Health Technology |
| Celltech Pharmaceuticals, Inc. | |
| Zurex PharmAgra LLC | |
Medeva Pharmaceuticals, Inc.
Medeva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of UCB SA, Medeva Pharmaceuticals, Inc. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Rochester, NY. Medeva Pharmaceuticals was founded in 1998. | Health Technology |
- Bolsa de valores
- Insiders
- Roy Andrew Morgan
